Replies to post #72 on Better Therapeutics Inc (BTTX)

[Eagle1]

Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
Company obtained FDA authorization for AspyreRxTM to treat adults with type 2 diabetes and announced commercial launch

https://www.businesswire.com/news/home/20231109425949/en/